RESEARCH AND INNOVATION

 

BLG GROUP has 6 major research centers. They have scientists working in facilities who have won Nobel Prizes. All PIs of the R&D team have doctoral degrees. Many of them have either studied and conducted research in Europe, America and Japan, or have worked in top research institutions around the world, worked in universities and served as doctoral supervisors。

 

BLG GROUP has established the Enzyme-based Technology Innovation Research Institute, a scientific research institution jointly established with Tianjin University of Science and Technology. It is based on enzymology, bio-enzyme engineering, microbial development engineering and biotechnology product application research and development. In addition they provide enzyme engineering, fermentation engineering technology and processes, as well as development and services to the society.

 

In 2024, BLG GROUP signed a cooperation agreement with Professor Carol Greider, a Nobel Prize-winning scientist in medicine, and Ameenah Gurib Fakim, a world-renowned female scientist, famous biologist, and the sixth President of Mauritius, to establish the "Nobel Prize Cooperation Laboratory" to jointly carry out research with the Enzyme-based Science and Technology Innovation Research Institute to jointly promote the leapfrog development of enzyme-based technology.

 

 

Professor Carol Greider won the 2009 Nobel Prize in Medicine for discovering the existence of telomerase and revealing its role in maintaining chromosome stability and regulating cell consumption.

 

BLG GROUP's unique innovative core technology, by improving the activity of enzymes and the effectiveness of bioactive substances, develops new enzyme-based raw materials and enzyme-based microecology, which complements Professor Carol Greider's research on telomerase activity regulation and cell protection. Through the cooperation of the joint laboratories of both parties, more effective results will be developed.